Zhejiang Xinguang Pharmaceutical Co., Ltd. (300519.SZ)
CNY 14.39
(-0.14%)
CNY 14.39
(-0.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 270.39 Million | 351.48 Million | 320.87 Million | 283.08 Million | 291.26 Million | 276.25 Million |
| Cost of Revenue | 158.79 Million | 169.23 Million | 142.13 Million | 126.53 Million | 132.07 Million | 124.48 Million |
| Gross Profit | 111.6 Million | 182.25 Million | 178.74 Million | 156.54 Million | 159.18 Million | 151.77 Million |
| Operating Expenses | 37.47 Million | 69.1 Million | 67.99 Million | 63.04 Million | 65.69 Million | 64.88 Million |
| Selling, General and Administrative Expenses | 22.31 Million | 36.45 Million | 35.51 Million | 35.32 Million | 34.87 Million | 32.03 Million |
| Research and Development Expenses | 15.13 Million | 15.54 Million | 13.51 Million | 12.01 Million | 15.89 Million | 17.77 Million |
| Other Expenses | 18.74 Thousand | -1 Million | -626.06 Thousand | 2.3 Million | -359.04 Thousand | -185.29 Thousand |
| Cost and Expenses | 196.26 Million | 238.33 Million | 210.13 Million | 189.58 Million | 197.77 Million | 189.36 Million |
| Operating Income | 48.93 Million | 126.6 Million | 132.58 Million | 112.49 Million | 108.63 Million | 101.04 Million |
| Interest Expense | 15.77 Thousand | 13.93 Thousand | 14.54 Thousand | 13.99 Thousand | 14.92 Thousand | 5.82 Million |
| Income Tax Expense | 8.8 Million | 16.78 Million | 17.67 Million | 15.82 Million | 14.37 Million | 12.86 Million |
| Earnings before Tax | 73.16 Million | 125.6 Million | 131.95 Million | 114.79 Million | 108.27 Million | 100.85 Million |
| Net Income | 64.35 Million | 108.82 Million | 114.28 Million | 98.97 Million | 93.9 Million | 87.99 Million |
| Earnings Per Share Basic | 0.40 | 0.68 | 0.71 | 0.62 | 0.59 | 0.55 |
| Earnings Per Share Diluted | 0.40 | 0.68 | 0.71 | 0.62 | 0.59 | 0.55 |
| Weighted Average Shares Outstanding | 160.89 Million | 160 Million | 160 Million | 160 Million | 160 Million | 159.99 Million |
| Weighted Average Shares Outstanding (Diluted) | 160.89 Million | 160 Million | 160 Million | 160 Million | 160 Million | 159.99 Million |
| Gross Margin | 0.41 | 0.52 | 0.56 | 0.55 | 0.55 | 0.55 |
| EBIT Margin | 0.33 | 0.36 | 0.40 | 0.38 | 0.36 | 0.34 |
| Profit Margin | 0.24 | 0.31 | 0.36 | 0.35 | 0.32 | 0.32 |
| EBITDA | 87.94 Million | 127.84 Million | 128.2 Million | 106.3 Million | 103.68 Million | 94.75 Million |
| Earnings Before Tax Margin | 0.18 | 0.36 | 0.41 | 0.40 | 0.37 | 0.37 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 70 Million | 44.98 Million | 98.9 Million | 54.28 Million | 270.39 Million | 67.07 Million |
| Cost of Revenue | 43.86 Million | 34.42 Million | 62.81 Million | 40.18 Million | 158.79 Million | 39.49 Million |
| Gross Profit | 26.13 Million | 10.55 Million | 36.08 Million | 14.09 Million | 111.6 Million | 27.58 Million |
| Operating Expenses | 12.36 Million | 12.28 Million | 13.84 Million | 16.78 Million | 60.34 Million | 14.22 Million |
| Selling, General and Administrative Expenses | 17.95 Million | 10.04 Million | 9.51 Million | -2.2 Million | - | 17.17 Million |
| Research and Development Expenses | 2.66 Million | 2.42 Million | 3.94 Million | 3.37 Million | - | 4.08 Million |
| Other Expenses | -8.24 Million | 179.53 Thousand | -377.43 Thousand | 19.07 Thousand | -972.92 Thousand | -1 Million |
| Cost and Expenses | 56.23 Million | 46.71 Million | 76.65 Million | 56.97 Million | 219.14 Million | 53.71 Million |
| Operating Income | 14.95 Million | -1.73 Million | 22.24 Million | 4.05 Million | 74.13 Million | 24.74 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 1.67 Million | -190.39 Thousand | 3.35 Million | -1.58 Million | 8.8 Million | 3.58 Million |
| Earnings before Tax | 13.95 Million | 2.48 Million | 26.18 Million | 4.07 Million | 73.16 Million | 23.74 Million |
| Net Income | 12.27 Million | 2.67 Million | 22.83 Million | 5.65 Million | 64.35 Million | 20.16 Million |
| Earnings Per Share Basic | 0.08 | 0.02 | 0.14 | 0.03 | - | 0.13 |
| Earnings Per Share Diluted | 0.08 | 0.02 | 0.14 | 0.03 | - | 0.13 |
| Weighted Average Shares Outstanding | 160 Million | 160 Million | 160 Million | 167.62 Million | 160.89 Million | 160 Million |
| Weighted Average Shares Outstanding (Diluted) | 160 Million | 160 Million | 160 Million | 167.62 Million | 160.89 Million | 160 Million |
| Gross Margin | 0.37 | 0.23 | 0.36 | 0.26 | 0.41 | 0.41 |
| EBIT Margin | 0.20 | 0.04 | 0.24 | -0.05 | - | 0.20 |
| Profit Margin | 0.18 | 0.06 | 0.23 | 0.10 | 0.24 | 0.30 |
| EBITDA | 13.77 Million | 1.93 Million | 23.67 Million | -2.7 Million | - | 13.47 Million |
| Earnings Before Tax Margin | 0.21 | -0.04 | 0.22 | 0.07 | 0.27 | 0.37 |
NEVPF
LFLO
SOBA
CZNL
FKYS
300504